BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 22615345)

  • 1. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.
    Steinberg BA; Zhao X; Heidenreich PA; Peterson ED; Bhatt DL; Cannon CP; Hernandez AF; Fonarow GC;
    Circulation; 2012 Jul; 126(1):65-75. PubMed ID: 22615345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
    Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Care and outcomes of Hispanic patients admitted with heart failure with preserved or reduced ejection fraction: findings from get with the guidelines-heart failure.
    Vivo RP; Krim SR; Krim NR; Zhao X; Hernandez AF; Peterson ED; Piña IL; Bhatt DL; Schwamm LH; Fonarow GC
    Circ Heart Fail; 2012 Mar; 5(2):167-75. PubMed ID: 22414939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Peterson ED; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2012 Mar; 163(3):430-7, 437.e1-3. PubMed ID: 22424014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.
    Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED
    Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study).
    Magaña-Serrano JA; Almahmeed W; Gomez E; Al-Shamiri M; Adgar D; Sosner P; Herpin D;
    Am J Cardiol; 2011 Nov; 108(9):1289-96. PubMed ID: 22000627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.
    Hsich EM; Grau-Sepulveda MV; Hernandez AF; Eapen ZJ; Xian Y; Schwamm LH; Bhatt DL; Fonarow GC
    Am Heart J; 2013 Dec; 166(6):1063-1071.e3. PubMed ID: 24268222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of care and outcomes in women hospitalized for heart failure.
    Klein L; Grau-Sepulveda MV; Bonow RO; Hernandez AF; Williams MV; Bhatt DL; Fonarow GC
    Circ Heart Fail; 2011 Sep; 4(5):589-98. PubMed ID: 21862732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Get With The Guidelines program participation, process of care, and outcome for Medicare patients hospitalized with heart failure.
    Heidenreich PA; Hernandez AF; Yancy CW; Liang L; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2012 Jan; 5(1):37-43. PubMed ID: 22235067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory pathways in patients with heart failure and preserved ejection fraction.
    Niethammer M; Sieber M; von Haehling S; Anker SD; Munzel T; Horstick G; Genth-Zotz S
    Int J Cardiol; 2008 Sep; 129(1):111-7. PubMed ID: 17658631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure with recovered ejection fraction: a distinct clinical entity.
    Punnoose LR; Givertz MM; Lewis EF; Pratibhu P; Stevenson LW; Desai AS
    J Card Fail; 2011 Jul; 17(7):527-32. PubMed ID: 21703523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R; Wang Y; Foody JM
    Am J Cardiol; 2008 Jan; 101(2):217-22. PubMed ID: 18178410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF).
    Forman DE; Cannon CP; Hernandez AF; Liang L; Yancy C; Fonarow GC;
    Am Heart J; 2009 Jun; 157(6):1010-7. PubMed ID: 19464411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcome in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and design.
    Santhanakrishnan R; Ng TP; Cameron VA; Gamble GD; Ling LH; Sim D; Leong GK; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN; Lam CS
    J Card Fail; 2013 Mar; 19(3):156-62. PubMed ID: 23482075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure with preserved versus reduced left ventricular systolic function: a prospective cohort of Shinken Database 2004-2005.
    Goda A; Yamashita T; Suzuki S; Ohtsuka T; Uejima T; Oikawa Y; Yajima J; Koike A; Nagashima K; Kirigaya H; Sagara K; Ogasawara K; Isobe M; Sawada H; Aizawa T
    J Cardiol; 2010 Jan; 55(1):108-16. PubMed ID: 20122556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
    Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
    Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction.
    Badheka AO; Rathod A; Kizilbash MA; Bhardwaj A; Ali O; Afonso L; Jacob S
    Am J Cardiol; 2011 Nov; 108(9):1283-8. PubMed ID: 21855829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.